Compare · MDT vs PXDT
MDT vs PXDT
Side-by-side comparison of Medtronic plc. (MDT) and Pixie Dust Technologies Inc. (PXDT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDT and PXDT operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- MDT carries a market cap of $131.60B.
- MDT has hit the wire 11 times in the past 4 weeks while PXDT has been quiet.
- MDT has more recent analyst coverage (25 ratings vs 0 for PXDT).
- Company
- Medtronic plc.
- Pixie Dust Technologies Inc.
- Price
- -
- -
- Market cap
- $131.60B
- -
- 1M return
- +8.58%
- -
- 1Y return
- +6.78%
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- NASDAQ
- IPO
- 2023
- News (4w)
- 11
- 0
- Recent ratings
- 25
- 0
Medtronic plc.
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Latest MDT
- Medtronic to acquire Contego Medical, expanding access to next-generation carotid therapies
- Orchestra BioMed Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates
- SEC Form SCHEDULE 13G filed by Medtronic plc.
- Imperative Care Announces Two New Board of Directors Appointments
- Orchestra BioMed Announces Pricing of Public Offering
- Orchestra BioMed Announces Proposed Public Offering
- President Marinaro Michael was granted 6,547 units of Ordinary Shares, increasing direct ownership by 6% to 113,353 units (SEC Form 4)
- Medtronic to announce financial results for its second quarter of fiscal year 2027
- /C O R R E C T I O N - The Michael J. Fox Foundation for Parkinson's Research/
- Michael J. Fox Foundation and Medtronic Partner to Help More People with Parkinson's Understand Deep Brain Stimulation
Latest PXDT
- SEC Form 6-K filed by Pixie Dust Technologies Inc.
- Amendment: SEC Form SC 13G/A filed by Pixie Dust Technologies Inc.
- Amendment: SEC Form SC 13G/A filed by Pixie Dust Technologies Inc.
- Amendment: SEC Form SC 13G/A filed by Pixie Dust Technologies Inc.
- Amendment: SEC Form SC 13D/A filed by Pixie Dust Technologies Inc.
- Amendment: SEC Form SC 13G/A filed by Pixie Dust Technologies Inc.
- SEC Form 25 filed by Pixie Dust Technologies Inc.
- /C O R R E C T I O N -- Pixie Dust Technologies/
- Amendment: SEC Form 6-K/A filed by Pixie Dust Technologies Inc.
- Notice regarding Plan to Delist American Depositary Receipts from NASDAQ Capital Market and Deregister with U.S. Securities and Exchange Commission.